Neoepitope vaccination strategies may also induce mutation-specific antibodies in antigen-driven expansion of B-cells that may also produce anti-cancer directed cytokines (262), functional TIB (263) that are associated with increased survival (264, 265) have been shown to produce antibodies that target TAAs, including mutant KRAS molecules (255). The gene discussed is KRAS; the disease is cancer.